Contrast-enhanced ultrasound as support for prostate brachytherapy treatment planning

Journal of Contemporary Brachytherapy

Volumn 4, Issue 2, 2012, Pages 69-74

  Pieters, Bradley ^a   Wijkstra, Hessel ^a   Van Herk, Marcel ^a   Kuipers, Ruud ^a   Kaljouw, Emmie ^a   De La Rosette, Jean ^a   Koning, Caro ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Brachytherapy planning; Contrast media; Image processing; Prostate; Ultrasonography

Indexed keywords

ARTICLE; BRACHYTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; EXTERNAL BEAM RADIOTHERAPY; HUMAN; IMAGE PROCESSING; IMPLANT; MALE; PROSTATE CANCER; RECTUM; TREATMENT PLANNING; URETHRA;

EID: 84864403435     PISSN: 1689832X     EISSN: None     Source Type: Journal    
DOI: 10.5114/jcb.2012.29362     Document Type: Article

References (28)

1. Villers A, McNeal JE, Freiha FS et al. Multiple cancers in the prostate. Cancer 1992; 70: 2313-2318.
2. Epstein JI, Walsh PC, Carmichael M et al. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA 1994; 271: 368-374. (Pubitemid 24037911)
3. Stamey TA, Freiha FS, McNeal JE et al. Localized prostate cancer. Cancer 1993; 71: 933-938.
4. van Lin ENJT, Fütterer JJ, Heijmink SWTPJ et al. IMRT boost dose planning on dominant intraprostatic lesions: Gold mark-er- based three dimensional fusion of CT with dynamic con-trast- enhanced and 1H-spectroscopic MRI. Int J Radiat Oncol Biol Phys 2006; 65: 291-303.
5. Fuchsjäger M, Shukla-Dave A, Akin O et al. Prostate cancer imaging. Acta Radiol 2008; 1: 107-120.
6. Puech P, Huglo D, Petyt G et al. Imaging of organ-confined prostate cancer: functional ultrasound, MRI and PET/computed tomography. Curr Opin Urol 2009; 19: 168-176.
7. Dickinson L, Ahmed HU, Allen C et al. Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European Consensus Meeting. Eur Urol 2011; 59: 477-494.
8. Heidenrich A. Consensus criteria for the use of magnetic resonance imaging in the diagnosis and staging of prostate cancer: not ready for routine use. Eur Urol 2011; 59: 495-497.
9. Jadvar H. Prostate cancer: PET with 18F-FDG, 18F- or 11C-acetate, and 18F- or 11C-choline. J Nucl Med 2011; 52: 81-89.
10. Wink M, Frauscher F, Cosgrove D et al. Contrast-enhanced ultrasound and prostate cancer; a multicentre European Re search Coordination Project. Eur Urol 2008; 54: 982-993.
11. Sedelaar JPM, van Leenders GJLH, Goossen TEB et al. Value of contrast ultrasonography in the detection of significant prostate cancer: correlation with radical prostatectomy specimens. The Prostate 2002; 53: 246-253. (Pubitemid 35266186)
12. Pallwein L, Mitterberger M, Pelzer A et al. Ultrasound of prostate cancer: recent advances. Eur Radiol 2008; 18: 707-715. (Pubitemid 351447775)
13. van Moerkerk H, Heijmink SWTPJ, Hulsbergen-van der Kaa CA et al. Computerized three-dimensional localization of prostate cancer using contrast-enhanced power Doppler and clustering analysis. Eur Urol 2006; 50: 762-769. (Pubitemid 44332665)
14. Halpern EJ, McCue PA, Aksnes AK et al. Contrast-enhanced US of the prostate with sonazoid: Comparison with wholemount prostatectomy specimens in 12 patients. Radiology 2002; 222: 361-366. (Pubitemid 34106105)
15. Seitz M, Gratzke C, Schlenker B et al. Contrast-enhanced transrectal ultrasound (CE-TRUS) with cadence-contrast pulse sequence (CPS) technology for the identification of prostate cancer. Urol Oncol 2011; 29: 295-301.
16. Mitterberger M, Aigner F, Pinggera GM et al. Contrast-enhanced colour Doppler-targeted prostate biopsy: correlation of a subjective blood-flow rating scale with the histopathological outcome of the biopsy. BJU International 2010; 106: 1315-1318.
17. Kuenen MPJ, Mischi M and Wijkstra H. Contrast-ultrasound diffusion imaging for localization of prostate cancer. IEEE Trans Med Imaging 2011; 30: 1493-1502.
18. Pieters BR, van der Grient JNB, Blank LECM et al. Minimal displacement of novel self-anchoring catheters suitable for temporary prostate implants. Radiother Oncol 2006; 80: 69-72. (Pubitemid 44226436)
19. Pieters BR, Geijsen ED, Koedooder K et al. Treatment results of PDR brachytherapy combined with external beam radiotherapy in 106 patients with intermediate- to high-risk prostate cancer. Int J Radiat Oncol Biol Phys 2011; 79: 1037-1042.
20. Wolthaus JW, van Herk M, Muller SH et al. Fusion of respiration- correlated PET and CT scans: correlated lung tumour motion in anatomical and functional scans. Phys Med Biol 2005; 50: 1569-1583. (Pubitemid 40524545)
21. Roche A, Pennec X, Malandain G et al. Rigid registration of 3-D ultrasound with MR images: a new approach combining intensity and gradient information. IEEE Trans Med Imaging 2001; 20: 1038-1049. (Pubitemid 33777721)
22. Korporaal JG, van den Berg CA, Groenendaal G et al. The use of probability maps to deal with uncertainties in prostate cancer delineation. Radiother Oncol 2010; 94: 168-172.
23. Engelbrecht MR, Jager GJ, Laheij RJ et al. Local staging of prostate cancer using magnetic resonance imaging: a meta-analysis. Eur Radiol 2002; 12: 2294-2303.
24. de la Rosette J, Ahmed H, Barentsz J et al. Focal therapy in prostate cancer. Report from a consensus panel. J Endourol 2010; 24: 775-780.
25. Moman MR, van den Berg CAT, Kruger AEB et al. Focal salvage guided by T2-weighted and dynamic contast-enhanced magnetic resonance imaging for prostate cancer recurrences. Int J Radiat Oncol Biol Phys 2010; 76: 741-746.
26. Nguyen PL, Chen M, D'Amico AV et al. Magnetic resonance image-guided salvage brachytherapy after radiation in select men who initially presented with favorable-risk prostate cancer. Cancer 2007; 110: 1485-1492. (Pubitemid 47463062)
27. Ménard C, Susil RC, Choyke P et al. MRI-guided HDR prostate brachytherapy in standard 1.5T scanner. Int J Radiat Oncol Biol Phys 2004; 59: 1414-1423.
28. Macura KJ, Stoianovici D. Advancements in magnetic resonance-guided robotic interventions in the prostate. Top Magn Reson Imaging 2008; 19: 297-304.